✦ LIBER ✦

Positive results for ibrutinib in B-cell malignancies

✍ Scribed by Kathryn Senior

Book ID: 119609125
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 73 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70506-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ibrutinib for B cell malignancies

✍ Novero, Aileen; Ravella, Pavan M; Chen, Yamei; Dous, George; Liu, Delong 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 238 KB

Ibrutinib in chronic lymphocytic leukemi

Ibrutinib in chronic lymphocytic leukemia and B cell malignancies

✍ Brown, Jennifer R. 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 210 KB

Ibrutinib in B-cell Lymphomas

✍ Maddocks, Kami; Blum, Kristie A. 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 185 KB

Trial watch: BTK inhibitor shows positiv

Trial watch: BTK inhibitor shows positive results in B cell malignancies

✍ Harrison, Charlotte 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Bruton Tyrosine Kinase Inhibitor Ibrutin

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies

✍ Advani, R. H.; Buggy, J. J.; Sharman, J. P.; Smith, S. M.; Boyd, T. E.; Grant, B 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 353 KB

Malignancies And False-Positive Serologi

Malignancies And False-Positive Serological Results For Hydatidosis

✍ S. Mansueto, G. Migneco, C. La Cascia and Maria Dora Miceli 📂 Article 📅 1980 🏛 BMJ Publishing Group 🌐 English ⚖ 357 KB